Harrow HROW Prepaid Prescription Drug User Fees
Prepaid Prescription Drug User Fees at other companies
Other financials
Where this comes from
Reported directly by Harrow in its filing.
Tagged under the XBRL concept HROW:PrepaidPrescriptionDrugUserFees.
The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harrow's prepaid prescription drug user fees.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harrow's prepaid prescription drug user fees?
- Harrow (HROW) reported prepaid prescription drug user fees of $2.89M in Q1 2026.
- How has Harrow's prepaid prescription drug user fees changed year-over-year?
- Harrow's prepaid prescription drug user fees increased by 18.5% year-over-year, from $2.43M to $2.89M.
- What is the long-term trend for Harrow's prepaid prescription drug user fees?
- Over 2 years (2023 to 2025), Harrow's prepaid prescription drug user fees has grown at a 12.2% compound annual growth rate (CAGR), from $3.44M to $4.33M.
- What does prepaid prescription drug user fees mean?
- Payments made to regulatory bodies in advance of product approval or annual maintenance requirements for pharmaceutical products. This reflects the company's investment in regulatory compliance and the pipeline development process.